A fetal echo in the third trimester showed left ventricular dilation, poor aortic valve function and severe mitral regurgitation. Is it a left ventricular aneurysm or dilated cardiomyopathy?
A case series suggests that patients with anatomically complex congenital heart disease typically addressed with single-ventricle palliation can fare well with a “ventricular switch” procedure that creates a two-ventricle circulation.
The first-ever cohort study to describe outcomes through adolescence among neonates with aortic atresia according to initial treatment finds a survival edge with primary heart transplant.
Cleveland Clinic Children’s is dedicated to delivering the highest quality medical care, for every care in the world. To mark this continued advancement, this post focuses on specialty outcomes measures.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
For any clinician with an interest in congenitally corrected transposition of the great arteries (CCTGA), this 2.5-day October CME event is can’t-miss.
Two experts share key takeaways from one of the most important congenital heart surgery trials of the past decade.
A large 20-year-old registry studying this congenital heart anomaly is starting to yield insights, and complementary prospective and retrospective Cleveland Clinic studies of adults with AAOCA promise to be useful adjuncts.
The move broadens the five-year-old relationship to more fully encompass both organizations’ pediatric and adult congenital cardiology programs.
We’re joining forces with Boston Children’s Hospital for a day and a half of powerhouse instruction on adult and pediatric CHD from multidisciplinary perspectives.
There’s currently no heart valve prosthesis small enough to fit in a newborn with a congenital mitral valve defect. A Cleveland Clinic team aims to change that with a novel device designed to “grow” with the child.